Krsnaa Diagnostics is currently trading at Rs. 386.70, up by 2.40 points or 0.62% from its previous closing of Rs. 384.30 on the BSE.
The scrip opened at Rs. 401.35 and has touched a high and low of Rs. 412.70 and Rs. 386.00 respectively. So far 10829 shares were traded on the counter.
The BSE group 'B' stock of face value Rs. 5 has touched a 52 week high of Rs. 655.00 on 28-Apr-2022 and a 52 week low of Rs. 354.00 on 28-Feb-2023.
Last one week high and low of the scrip stood at Rs. 422.20 and Rs. 372.35 respectively. The current market cap of the company is Rs. 1222.62 crore.
The promoters holding in the company stood at 27.80%, while Institutions and Non-Institutions held 23.55% and 48.66% respectively.
Krsnaa Diagnostics has operationalized 100 more Pathology Collection Centers in Mumbai. With this, the Company has operationalized 300 Pathology collection center as on the date of March 13, 2023.
Earlier, the company had secured tender from Brihanmumbai Municipal Corporation, Mumbai, Maharashtra to provide services of Lab Investigation Facilities under ‘Hinduhridaysamrat Balasaheb Thakeray Chikitsa’ for BMC Dispensaries and Hospitals in Mumbai, Maharashtra on Public Private Partnership (PPP) basis.
Krsnaa Diagnostics is one of the fastest-growing diagnostic chains in India.
| Company Name | CMP |
|---|---|
| Apollo Hospital Ent. | 7699.05 |
| Max Healthcare Inst | 1006.90 |
| Narayana Hrudayalay | 1825.55 |
| Aster DM Healthcare | 688.30 |
| Global Health | 1089.55 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: